Perrigo RECEIVES FDA Approval and 2 Stocks Breaking to 52-Week Highs
Perrigo Company (NASDAQ:PRGO) shares closed up 1.28 percent at $116.76, on word that it has received final FDA approval for its abbreviated new drug application for clindamycin phosphate and benzoyl...
View ArticleGeron Corp. HALTS Trial and 4 Hot Stocks Attracting Attention
Geron Corporation (NASDAQ:GERN): On Monday, the company stated that it stopped a mid-stage trial of imetelstat as a breast cancer treatment because women treated with the drug were not doing as well as...
View ArticleUniFirst Earnings: Everything You Must Know Now
UniFirst Corp. (NYSE:UNF) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the...
View ArticleClik here to view.
SAIC May Face Down Apple Appeal and 3 Stocks At 52-Week Highs
SYNNEX Corp. (NYSE:SNX): Closing price $40.88 SYNNEV is due to report after the Wednesday market close, with earnings consensus of 88 cents. Shares closed up 0.57 percent on the day at $40.88, and have...
View ArticleClik here to view.
4 Stocks Energizing Investors After Earnings
UniFirst Corp. (NYSE:UNF) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 38.54% to $1.33 in the quarter versus EPS of...
View ArticleClik here to view.
Greenhill Director Sells 15K Shares and 3 Insider Sales to Note
Greenhill & Co Inc who is Director by Deputization at Greenhill & Co., Inc. (NYSE:GHL), sold 15,000 shares at $6.68 per share for a total value of $100,173. The shares recently traded at...
View ArticleUniFirst Earnings: Everything You Must Know Now
UniFirst Corp. (NYSE:UNF) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high...
View ArticleClik here to view.
These 4 Stocks Saw Trading Price Swings This Past Week Post Earnings
AZZ Incorporated (NYSE:AZZ) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 9.8% to $0.56 in the...
View Article